Join to View Full Profile
5670 Peachtree Dunwoody RdSte 1000Atlanta, GA 30342
Phone+1 404-255-1930
Fax+1 404-459-8510
Dr. Solh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2008 - 2011
American University of Beirut Faculty of MedicineClass of 2003
Certifications & Licensure
GA State Medical License 2014 - 2027
FL State Medical License 2011 - 2015
MN State Medical License 2008 - 2011
MI State Medical License 2004 - 2008
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia Start of enrollment: 2016 Sep 09
Publications & Presentations
PubMed
- CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.Yannis K Valtis, Chenyu Lin, David Nemirovsky, Sean Devlin, Kai Rejeski
Blood Advances. 2026-01-13 - The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia.Timothy E O'Connor, Chenyu Lin, Gregory W Roloff, Amy Zhang, Katharine Miller
Bone Marrow Transplantation. 2025-11-01 - 2 citationsImpact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia.Mark J Levis, Mehdi Hamadani, Brent R Logan, Richard J Jones, Anurag K Singh
Blood Advances. 2025-10-28
Abstracts/Posters
- Real World Outcomes of Letermovir Prophylaxis in Unselected High Risk CMV Seropositive Hematopoietic Stem Cell Transplant RecipientsMelhem Solh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Improved Survival in Patients Who Undergo Relapse of Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell TransplantationMelhem Solh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Interim Futility Analysis of a Phase 2 Study of Loncastuximab Tesirine, a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Patients with Relapsed or Refra...Melhem Solh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Graft Versus Host Disease (GVHD) after HLA-Mismatched Haploidentical Transplantation with Post-Transplant Cyclophosphamide Compared to Matched Unrelated Donor: Inciden...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Psychological and Social Factors Are a Strong Predictor of Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Independent of Disease Risk and Mor...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- A Phase II Trial of Melphalan Based Reduced Intensity Conditioning and Transplantation of Partially HLA-Mismatched Peripheral Blood Stem Cells for Patients with Hemato...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
Northside Offers Groundbreaking Melanoma TherapyApril 2nd, 2024- New Anti-BCMA CAR T-cell Therapy Offered at Northside HospitalJuly 6th, 2021
Initial FLAG-Ida Outperforms 7+3 for High-Risk AMLFebruary 24th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
